Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-011854

Chief Operating Officer sold 70,441 shares

  • Chief Operating Officer acquired 70,441 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kling Douglas F · Chief Operating Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Owned after D/I
2025-01-29 Exercise or conversion : show line 1 in the form 10b5-1 +56,863 100,863 D
2025-01-29 Sale : show line 2 in the form 10b5-1 −56,863 44,000 D
2025-01-30 Exercise or conversion : show line 3 in the form 10b5-1 +13,578 57,578 D
2025-01-30 Sale : show line 4 in the form 10b5-1 −4,664 52,914 D
2025-01-30 Sale : show line 5 in the form 10b5-1 −8,914 44,000 D
Open-market sales · 70,441 sh

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-01-29 Exercise or conversion : show line 6 in the form 10b5-1 Option (right to buy) −56,863 239,723 D
2025-01-30 Exercise or conversion : show line 7 in the form 10b5-1 Option (right to buy) −13,578 226,145 D
Loading xslF345X05/ownership.xml…